| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | ||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2024 | Aug 29, 2024 | Ackerman Joel CFO Treasuer | Sell | Davita Inc. | DVA | $155.06 | 68,769 | $11M | -39.18% |
| Aug 05, 2021 | Aug 06, 2021 | Ackerman Joel CFO Treasurer | Sell | Davita Inc. | DVA | $131.36 | 37,760 | $5M | -51.54% |
| Oct 01, 2018 | Oct 03, 2018 | Ackerman Joel Dir | Sell | Champions Oncology, Inc. | CSBR | $17.02 | 22,535 | $383,546 | -2.16% |
| Oct 18, 2016 | Oct 20, 2016 | Ackerman Joel CEO | Buy | Champions Oncology, Inc. | CSBR | $1.7 | 2,000 | $3,393 | +0.19% |
| Oct 13, 2016 | Oct 14, 2016 | Ackerman Joel CEO | Buy | Champions Oncology, Inc. | CSBR | $1.67 | 7,300 | $12,205 | +0.70% |
| Oct 06, 2016 | Oct 07, 2016 | Ackerman Joel CEO | Buy | Champions Oncology, Inc. | CSBR | $1.63 | 8,202 | $13,369 | +0.79% |
| Sep 23, 2016 | Sep 26, 2016 | Ackerman Joel CEO | Buy | Champions Oncology, Inc. | CSBR | $1.65 | 33 | $54 | +0.00% |
| Sep 20, 2016 | Sep 21, 2016 | Ackerman Joel CEO | Buy | Champions Oncology, Inc. | CSBR | $1.66 | 5,000 | $8,324 | +0.48% |
| Mar 11, 2015 | Mar 17, 2015 | Ackerman Joel CEO | Buy | Champions Oncology, Inc. | CSBR | ~ | 3M | $0 | +42.66% |